Antihyperlipidemics Flashcards
What are the HMG Co reductase inhibitors and MOA
rosuvastatin and other “statins”
MOA: inhibit HMG CoA –> Mevalonate (cholesterol percursor)
Decreased liver cholesterol
Increased LDL-receptor expression
Decreased plasma LDL
Decreased VLDL synthesis results in: ↓triglyceridemia
HMG Co reductase inhibitors side effects and drug interactions
Side effects:
– Myalgia,myopathy (check creatine kinase)
– Rhabdomyolysis
– Hepatotoxicity (check liver function tests)
Drug interaction:
– Gemfibrozil (fibrates) ↑rhabdomyolysis
– CytochromeP450 inhibitors enhance toxicity of statins
What are the Bile Acid Resins and MOA
cholestyramine, colestipol, colesvelam
Prevent intestinal reabsorption of bile acids; liver must use cholesterol to make more
Bile Acid Resins side effects and drug interactions and contraindications
Side effects: – Increase VLDL and triglycerides – Gastrointestinal disturbances – Malabsorption of lipid-soluble vitamins – Hyperglycemia
Drug interactions with orally administered drugs (warfarin, thiazides, digoxin, etc.)
Contraindication: hypertriglyceridemia
Ezetimbe MOA and side effect
Prevent cholesterol absorption at small intestine brush border (NPC1L1) results in ↓ LDL
GI distress
PCSK9 inhibitors and MOA
Alirocumab, evolocumab
Inactivation of LDL-receptor degradation, increasing LDL receptor number and amount of LDL removed from bloodstream
PCSK9 inhibitors side effects
Myalgias, delirium, dementia, other neurocognitive effect
Niacin, Vitamin B3 MOA and side effect
Inhibits lipolysis (hormone- sensitive lipase) in adipose tissue; reduces hepatic VLDL synthesis
inhibition of VLDL synthesis, results in:
– Decreased plasma VLDL
– Decreased plasma LDL
– Increasedplasma HDL
Side effects:
Red, flushed face, which is decreased by NSAIDs or long-term use
Hyperglycemia
Heptatoxcitiy
Fibrates and the MOA and side effects
Gemfibrozil, bezafibrate, fenofibrate
Upregulate LPL to stimulate TG clearance,
Activates PPAR-α to induce HDL synthesis
upregulation of LPL, apoA-I, apoA-II, and for downregulating apo CIII (inhibitor of lipolysis)
– Decreased VLDL and IDL
– Modest ↓LDL (however,in some patients with combined hyperlipidemias, ↑ LDL)
– Increased HDL (most patients)
– Used in hypertriglyceridemia
SE: Gallstones, myositis (increase risk with statins)
Statins are contraindicated in
Pregnant/lactating women and persons >8y/o
Omega 3 Fatty Acid
decrease hepatic TG synthesis
Rx for Familial Hypercholesterolemia
Lomitapide - microsomal TG transfer protein inhibition
Mipomersen - destroy Apo B 100 mRNA
Orlistat
weight loss
inhibit pancreatic lipase which decreases TG breakdown
SE: oily stool